The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic, translational, and clinical proof-of-concept research projects that are needed for the advancement of bioengineering approaches for heart, lung, blood and sleep diseases.
- Letter of Intent Due Date(s): 30 days before the application due date
- Application Due Date(s): New Dates October 13, 2016; January 10, 2017; May 10, 2017; January 10, 2018; May 10, 2018
- AIDS Due Dates: Jan. 7, May 7, Sep. 7
RFA-HL-17-015 Expiration Date New Date September 8, 2018 per issuance of NOT-HL-17-567. (Original Expiration Date: May 11, 2019)
Direct costs are limited to $275,000 over a two-year period, with no more than $150,000 in direct costs allowed in any single year.